A new study has confirmed that male and female lungs are "wired differently" at the molecular level, providing further ...

Physicists in Leiden have built a microscope that can measure no fewer than four key properties of a material in a single ...

Watch traditional blacksmithing as tool chest hinges are forged, showcasing precise craftsmanship and metalworking skills.

BBC health correspondent James Gallagher gets his blood analysed to understand how air pollution is killing us.

The disease is the rare cancer met with accusations, not sympathy. By Simar Bajaj Simar Bajaj spoke to over a dozen patients with lung cancer for this story. When Jim Pantelas was diagnosed with lung ...

Current lung cancer screening guidelines restrict eligibility to a select group of longer-term smokers A new study finds that under the guidelines, almost two-thirds of lung cancer patients wouldn't ...

Pulmonx Corporation (NASDAQ:LUNG) is one of the best stocks under $3 to invest in. On October 28, Lake Street lowered the firm’s price target on Pulmonx to $4 from $8 and kept a Buy rating on the ...

Rachel Feltman: For Scientific American’s Science Quickly, I’m Rachel Feltman. Lung cancer is the deadliest cancer among women in the United States, surpassing the mortality numbers of breast and ...

President Trump has been a cheerleader for coal miners. But these miners say his administration is failing to enforce limits on a lethal workplace hazard. Gary Hairston, 71, is a retired coal miner ...

3D-printed lungs made with living cells could help to improve lung disease prevention and treatment—and potentially one day offer a lab-grown option for use in organ transplants. University of ...

WEST HILLS, Calif.--(BUSINESS WIRE)--Thermo Fisher Scientific, the world leader in serving science, has introduced a new laboratory developed test for post-transplant biopsy assessment designed to ...

Summit Therapeutics Inc. (NASDAQ:SMMT), on Sunday, revealed the updated overall survival (OS) results from the global Phase 3 HARMONi trial of ivonescimab at the 2025 World Conference on Lung Cancer ...